말초혈관 디바이스 시장 : 제품 유형, 기술 유형, 재료 유형, 적응증, 환자 유형, 최종사용자별 - 세계 예측(2025-2030년)

The Peripheral Vascular Devices Market was valued at USD 13.90 billion in 2023 and is projected to grow to USD 14.66 billion in 2024, with a CAGR of 5.95%, reaching USD 20.85 billion by 2030.

The peripheral vascular devices market represents a critical segment in modern healthcare that continues to evolve under the pressure of rising chronic diseases and the increasing demand for minimally invasive therapies. In this market, innovation drives not only improved patient outcomes but also operational efficiencies and cost reductions for healthcare providers. Today, the rapid pace of technological advancement combined with the dynamic needs of clinicians and patients has positioned peripheral vascular devices as a pivotal area of focus.

These devices, which range from stents to grafts, embody the intersection of engineering excellence and medical needs, creating opportunities to address complex vascular conditions with enhanced precision. The evolving healthcare landscape is marked by shifting regulatory standards, deeper scientific understanding of vascular conditions, and an unwavering shift towards less invasive treatment options. As digital health and advanced manufacturing techniques integrate into this space, the role of peripheral vascular devices becomes even more central to the success of cardiovascular interventions around the globe.

This summary serves to provide a comprehensive overview that highlights not only the market's current state but also the transformative trends, segmentation insights, regional dynamics, leading company activities, and actionable recommendations for future growth. The narrative that follows will help decision-makers, investors, and healthcare experts grasp the nuances of this market's potential in a rapidly changing environment.

Transformative Shifts in the Peripheral Vascular Devices Landscape

Over the past decade, the peripheral vascular devices market has undergone a series of transformative shifts driven by technology, regulation, and demographics. One of the most significant changes has been the transition from traditional open surgeries to minimally invasive procedures. These procedures not only reduce recovery times but also minimize the risks associated with more invasive interventions, thereby improving patient satisfaction and widening the scope for outpatient treatments.

Technological advancements have reshaped the market by introducing innovative devices that offer enhanced control and precision. These developments have, for example, enabled engineers to design stents and guidewires with improved flexibility and durability while also leveraging smart materials that can respond to physiological changes within the body. Manufacturers now focus on integrating data analytics and real-time imaging capabilities into device design, a shift that is continuously driving efficiency and improving safety outcomes.

Additionally, the market has seen an increased emphasis on personalized healthcare solutions. Patient-specific devices, created as a result of advanced imaging modalities and precision engineering, are now more attainable than ever. Regulatory reforms have facilitated a faster time-to-market while ensuring that these devices adhere to stringent safety and performance standards. With the brown field of legacy products making way for innovative, patient-tailored therapies, the trend towards precision medicine in peripheral vascular applications is both inevitable and welcome.

These market dynamics, influenced by the convergence of technological prowess and evolving clinical practices, have led not only to enhanced therapeutic outcomes but also to a more competitive global marketplace. The combination of reduced procedural risks, streamlined manufacturing processes, and improved clinical results is paving the way for sustained growth and investment in the sector.

Key Segmentation Insights in Peripheral Vascular Devices

A thorough appraisal of the peripheral vascular devices market reveals a highly segmented structure that facilitates a deeper understanding of the opportunities at various levels. The market is dissected based on product type, technology, material, indication, patient profile, and end-user. Regarding product segmentation, the domain encompasses balloon inflation devices, catheters, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure devices. Distinctively, the catheter category experiences further granularity by distinguishing long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters, highlighting the variations in treatment nuances across different clinical settings. Similarly, grafts subdivide into biological grafts, ePTFE grafts, and polyester grafts, while stents further divide into balloon-expandable stents and self-expanding stents.

When considering technology type, the market equally splits between minimally invasive surgeries and open surgeries. Minimally invasive procedures are further examined under the banners of angioplasty and stenting, which collectively represent a significant portion of the interventions due to their reduced operative risk and quicker patient recovery times. In contrast, open surgery, categorized into bypass surgery and endarterectomy, remains indispensable for complex scenarios where less invasive approaches may not suffice.

Material composition analysis shows that the market is bracketed by metal and non-metal devices. Metal devices often feature substances like cobalt chromium, nitinol, and stainless steel because of their robustness and an ability to conform to intricate vascular structures, while non-metal solutions utilize polymer and silicone materials that emphasize flexibility and compatibility with bodily tissues. Such segmentation demonstrates how material science innovations translate into device functionality and durability.

Furthermore, an examination of indications reveals two broad categories: functional and occlusive peripheral vascular diseases. Functional conditions, which include ailments such as chronic venous insufficiency, Raynaud's disease, and varicose veins, demand devices that ensure consistent and comfortable vascular support. On the other hand, occlusive conditions like atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema require a more aggressive intervention strategy where device efficacy can directly influence patient prognosis.

Patient demographics further enrich segmentation with classifications into adult & geriatric and pediatric populations. The former is signified by acute and chronic conditions where devices play a crucial role in managing long-term health. Pediatric cases, whether stemming from acquired or congenital conditions, demand specialized device considerations given the unique physiological challenges of younger patients. Finally, the market segmentation by end-user demonstrates that the distribution channels include ambulatory surgical centers, clinics, and hospitals, each creating unique demand patterns and influencing the design and usage of devices across the spectrum of clinical practice.

These intricately defined segmentation layers provide valuable insights that enable stakeholders to pinpoint emerging opportunities, tailor product innovations, and devise targeted strategies for optimal market penetration.

Based on Product, market is studied across Balloon Inflation Devices, Catheters, Grafts, Guidewires, Inferior Vena Cava Filters, Introducers, Plaque Modification Devices, Stents, and Vascular Closure Devices. The Catheters is further studied across Long Peripheral Intravenous Catheters, Midline Catheters, and Short Peripheral Intravenous Catheter. The Grafts is further studied across Biological Grafts, ePTFE Grafts, and Polyester Grafts. The Stents is further studied across Balloon-Expandable Stents and Self-Expanding Stents.

Based on Technology Type, market is studied across Minimally Invasive Surgeries and Open Surgery. The Minimally Invasive Surgeries is further studied across Angioplasty and Stenting. The Open Surgery is further studied across Bypass Surgery and Endarterectomy.

Based on Material Type, market is studied across Metal Devices and Non-Metal Devices. The Metal Devices is further studied across Cobalt Chromium, Nitinol, and Stainless Steel. The Non-Metal Devices is further studied across Polymer and Silicone.

Based on Indication, market is studied across Functional Peripheral Vascular Disease and Occlusive Peripheral Vascular Disease. The Functional Peripheral Vascular Disease is further studied across Chronic Venous Insufficiency, Raynaud's Disease, and Varicose Veins. The Occlusive Peripheral Vascular Disease is further studied across Atherosclerosis, Buerger's Disease, Carotid Artery Disease, Deep Vein Thrombosis, and Lymphedema.

Based on Patient Types, market is studied across Adult & Geriatric and Pediatric. The Adult & Geriatric is further studied across Acute Conditions and Chronic Conditions. The Pediatric is further studied across Acquired Conditions and Congenital Conditions.

Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.

Regional Insights Shaping Market Opportunities

The geographic landscape of the peripheral vascular devices market is characterized by diverse regional trends that mirror distinct healthcare infrastructures and economic conditions. In the Americas, robust healthcare expenditure combined with advanced technological adoption drives market growth, where the integration of advanced devices in routine clinical practice is routinely observed. The region benefits from established regulatory frameworks that support innovation and create a conducive environment for research and development.

In Europe, the Middle East & Africa, healthcare systems are equally attuned to the benefits of state-of-the-art vascular interventions. This region experiences a blend of mature markets in Western Europe, emerging markets in Africa, and dynamic growth pockets in the Middle East. Variations in healthcare policies and reimbursement scenarios have resulted in a landscape where strategic partnerships and collaborations are vital to drive device adoption. Innovations in device manufacturing, particularly in terms of miniaturization and improved material properties, are notably well-received, further fostering market expansion in these areas.

Asia-Pacific stands at the forefront of market dynamism, driven by rapid urbanization, increasing healthcare awareness, and a surge in government initiatives aimed at improving healthcare infrastructure. The region's large population base coupled with rising disposable incomes ensures a significant demand for cutting-edge peripheral vascular devices. The market in Asia-Pacific is marked by an accelerating shift towards minimally invasive procedures as state-of-the-art surgical techniques become the norm in leading hospitals and urban clinics. Collectively, these regional insights underscore the importance of tailored strategies that take into account the unique economic and regulatory conditions inherent to each market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Leading the Peripheral Vascular Devices Sector

A closer examination of the competitive landscape reveals several key players that command significant influence over the peripheral vascular devices market. Market pioneers such as Abbott Laboratories and AMECATH have established robust portfolios that underscore their commitment to innovative solutions. Companies like AngioDynamics, Inc. and Argon Medical Devices, Inc. are known for their emphasis on research and development, ensuring that their products continuously integrate the latest technological advancements.

American industry leaders such as ASAHI INTECC CO., LTD demonstrate a high level of precision in device engineering, while firms like B. Braun SE and Baxter International Inc. continue to build on longstanding legacies of reliability and performance. Traditional industry stalwarts, including Becton, Dickinson and Company and BIOTRONIK SE & Co. KG, leverage a history of clinical excellence to bolster their market positions. Meanwhile, companies such as Boston Scientific Corporation and Cardinal Health, Inc. deliver comprehensive solutions that holistically address vascular challenges.

Cook Group Incorporated and Cordis further contribute to a competitive market environment with their innovative technology platforms that are reaping remarkable clinical benefits. Esaote S.p.A. and FUJIFILM Holdings Corporation have also made significant advances, integrating digital diagnostic capabilities with interventional device technologies. Industry leaders like GE HealthCare and Kimal PLC remain at the forefront of research and design, while Koninklijke Philips N.V. and Lepu Medical Technology (Beijing) Co., Ltd. continue to push the envelope in imaging and device synergy. Medtronic PLC and Merit Medical Systems, Inc. are prominent examples of companies that have built deep, diversified portfolios to meet a wide range of clinical needs.

Furthermore, the competitive landscape is buoyed by the contributions of Nipro Corporation, Penumbra, Inc., Sahajanand Medical Technologies Limited, and Shockwave Medical, Inc. by Johnson & Johnson Services, Inc. Their efforts in combining engineering precision with clinical insight underscore the sector's focus on outcome-based solutions. Siemens Healthineers AG, Summa Therapeutics, LLC, Teleflex Incorporated, Terumo Corporation, and W. L. Gore & Associates, Inc. round out a market populated by the most capable and innovative entities. The cumulative effect of this competitive environment is a continuous push for quality, cost-effectiveness, and technological advancement across the entire market.

The report delves into recent significant developments in the Peripheral Vascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMECATH, AngioDynamics, Inc., Argon Medical Devices, Inc., ASAHI INTECC CO., LTD, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Cordis, Esaote S.p.A., FUJIFILM Holdings Corporation, GE HealthCare, Kimal PLC, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra, Inc., Sahajanand Medical Technologies Limited, Shockwave Medical, Inc. by Johnson & Johnson Services, Inc., Siemens Healthineers AG, Summa Therapeutics, LLC, Teleflex Incorporated, Terumo Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Industry Leaders

Decision-makers in the peripheral vascular devices market should capitalize on existing opportunities while preparing strategically for future challenges. One of the foremost recommendations is to invest heavily in research and development to continue driving innovative breakthroughs, particularly in the areas of minimally invasive surgery and personalized device design. It is vital to integrate advanced materials and incorporate digital health technologies that can provide real-time data to inform procedural improvements. Fostering partnerships between academia, clinical research centers, and manufacturers can help streamline the adoption of cutting-edge technologies.

Leaders should also consider diversifying product portfolios to include both metal and non-metal device options, ensuring that the range of products stays relevant across diverse patient profiles and complex vascular conditions. Moreover, adopting a segmentation-focused approach can serve companies well by allowing for precise targeting of treatments based on patient type and disease indication. By closely monitoring market segmentation trends and consumer behavior, companies can adjust their strategies to better cater to the distinct needs of adult, geriatric, and pediatric patient groups.

Expanding geographic footprint remains an essential tactic as well. Firms should leverage emerging markets in Asia-Pacific and regions with robust growth potential such as parts of Europe and the Middle East & Africa. This geographic diversification not only mitigates risk but also exposes companies to a wider array of opportunities, thereby ensuring sustained revenue growth.

Furthermore, industry leaders are encouraged to focus on operational excellence by optimizing supply chains and reinforcing quality assurance protocols. In an era where both regulatory demands and patient expectations are intensifying, aligning internal processes with global standards is paramount. Companies must balance innovation with precision in execution to ensure that high-quality products are accessible, economically feasible, and clinically effective.

Finally, proactive engagement with regulators and policy makers can help shape a favorable operating environment that encourages innovation while safeguarding patient health. Such collaboration is essential for accelerating device approvals and facilitating smoother market entry processes for next-generation products.

Conclusion: The Road Ahead in Peripheral Vascular Devices

In summary, the peripheral vascular devices market is poised for a new era marked by technological innovation, refined segmentation strategies, and expansive regional growth. The shift towards minimally invasive procedures and precision medicine has fundamentally redefined therapeutic strategies, ensuring that patient outcomes are continually improved. This evolution is supported by a wide array of product offerings, differentiated by material, indication, technology, and patient type, which together create a versatile and resilient market ecosystem.

The competitive landscape is vibrant, driven by leading companies that are steadfast in their commitment to clinical excellence and innovation. Such players continually refine their strategies and portfolios in response to emerging trends, thereby fostering a climate of healthy competition and sustainable growth. By aligning research, investment, and operational practices, the industry is well-prepared to address the evolving challenges of healthcare delivery on a global scale.

Looking forward, a collaborative approach that bridges clinical expertise, regulatory alignment, and technological advancement will be critical to unlocking the full potential of the peripheral vascular devices market. As the industry navigates an increasingly complex and competitive landscape, the convergence of these factors will define the future of vascular treatment modalities and drive long-term market sustainability.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. The increasing prevalence of peripheral vascular diseases
    • 5.1.1.2. Rising preference for minimally invasive treatment options
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and product recalls associated peripheral vascular devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing advancement in the peripheral vascular devices
    • 5.1.3.2. Governmental support and investment in healthcare infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations for approval and disposal of medical devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Proliferating usage of the catheters for prolonged therapy administration
  • 5.2.2. Technology Type: Rapid adoption of minimally invasive procedures fueled by patient demand for quicker recoveries and less traumatic experiences
  • 5.2.3. Material Type: Burgeoning utilization of non-metal devices providing superior biocompatibility and reduced thrombus formation
  • 5.2.4. Indication: Evolving usage of peripheral vascular devices for occlusive peripheral vascular disease (OPVD) driven by critical, life-preserving interventions
  • 5.2.5. Patient Types: Significant application of peripheral vascular devices the in adult patients
  • 5.2.6. End-User: Expanding applications of peripheral-vascular-devices across hospitals settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Peripheral Vascular Devices Market, by Product

• 6.1. Introduction
• 6.2. Balloon Inflation Devices
• 6.3. Catheters
  • 6.3.1. Long Peripheral Intravenous Catheters
  • 6.3.2. Midline Catheters
  • 6.3.3. Short Peripheral Intravenous Catheter
• 6.4. Grafts
  • 6.4.1. Biological Grafts
  • 6.4.2. ePTFE Grafts
  • 6.4.3. Polyester Grafts
• 6.5. Guidewires
• 6.6. Inferior Vena Cava Filters
• 6.7. Introducers
• 6.8. Plaque Modification Devices
• 6.9. Stents
  • 6.9.1. Balloon-Expandable Stents
  • 6.9.2. Self-Expanding Stents
• 6.10. Vascular Closure Devices

7. Peripheral Vascular Devices Market, by Technology Type

• 7.1. Introduction
• 7.2. Minimally Invasive Surgeries
  • 7.2.1. Angioplasty
  • 7.2.2. Stenting
• 7.3. Open Surgery
  • 7.3.1. Bypass Surgery
  • 7.3.2. Endarterectomy

8. Peripheral Vascular Devices Market, by Material Type

• 8.1. Introduction
• 8.2. Metal Devices
  • 8.2.1. Cobalt Chromium
  • 8.2.2. Nitinol
  • 8.2.3. Stainless Steel
• 8.3. Non-Metal Devices
  • 8.3.1. Polymer
  • 8.3.2. Silicone

9. Peripheral Vascular Devices Market, by Indication

• 9.1. Introduction
• 9.2. Functional Peripheral Vascular Disease
  • 9.2.1. Chronic Venous Insufficiency
  • 9.2.2. Raynaud's Disease
  • 9.2.3. Varicose Veins
• 9.3. Occlusive Peripheral Vascular Disease
  • 9.3.1. Atherosclerosis
  • 9.3.2. Buerger's Disease
  • 9.3.3. Carotid Artery Disease
  • 9.3.4. Deep Vein Thrombosis
  • 9.3.5. Lymphedema

10. Peripheral Vascular Devices Market, by Patient Types

• 10.1. Introduction
• 10.2. Adult & Geriatric
  • 10.2.1. Acute Conditions
  • 10.2.2. Chronic Conditions
• 10.3. Pediatric
  • 10.3.1. Acquired Conditions
  • 10.3.2. Congenital Conditions

11. Peripheral Vascular Devices Market, by End-User

• 11.1. Introduction
• 11.2. Ambulatory Surgical Centers
• 11.3. Clinics
• 11.4. Hospitals

12. Americas Peripheral Vascular Devices Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Peripheral Vascular Devices Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Peripheral Vascular Devices Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. AngioDynamics launches RECOVER-AV clinical trial to expand AlphaVac F1885 System usage in Europe
  • 15.3.2. Shockwave Medical's advanced catheter aims to redefine treatment landscape for complex peripheral artery disease
  • 15.3.3. Medtronic pioneers innovation in aortic procedures with the launch of Steerant aortic guidewire for endovascular aneurysm repair (EVAR) and thoracic EVAR (TEVAR)
  • 15.3.4. Philips unveils the Duo Venous Stent System revolutionizing treatment for venous outflow obstructions
  • 15.3.5. Abbott's revolutionary Esprit BTK dissolving stent sets a new standard in peripheral artery disease management
  • 15.3.6. AngioDynamics' AlphaVac F18 85 system gains FDA clearance, establishing a new standard in pulmonary embolism treatment strategies
  • 15.3.7. Strategic alliance between Zylox-Tonbridge and Avinger expands innovative OCT solutions in vascular interventions
  • 15.3.8. BD launches AGILITY study to assess innovative covered stent, aiming to expand peripheral arterial disease (PAD) treatment options worldwide
  • 15.3.9. Summa Therapeutics' Finesse catheter revolutionizes below-the-knee (BTK) angioplasty with innovative, multifunctional design
• 15.4. Strategy Analysis & Recommendation
  • 15.4.1. Abbott Laboratories
  • 15.4.2. Merit Medical Systems, Inc.
  • 15.4.3. Boston Scientific Corporation
  • 15.4.4. Medtronic PLC

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMECATH
• 3. AngioDynamics, Inc.
• 4. Argon Medical Devices, Inc.
• 5. ASAHI INTECC CO., LTD
• 6. B. Braun SE
• 7. Baxter International Inc.
• 8. Becton, Dickinson and Company
• 9. BIOTRONIK SE & Co. KG
• 10. Boston Scientific Corporation
• 11. Cardinal Health, Inc.
• 12. Cook Group Incorporated
• 13. Cordis
• 14. Esaote S.p.A.
• 15. FUJIFILM Holdings Corporation
• 16. GE HealthCare
• 17. Kimal PLC
• 18. Koninklijke Philips N.V.
• 19. Lepu Medical Technology (Beijing) Co., Ltd.
• 20. Medtronic PLC
• 21. Merit Medical Systems, Inc.
• 22. Nipro Corporation
• 23. Penumbra, Inc.
• 24. Sahajanand Medical Technologies Limited
• 25. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
• 26. Siemens Healthineers AG
• 27. Summa Therapeutics, LLC
• 28. Teleflex Incorporated
• 29. Terumo Corporation
• 30. W. L. Gore & Associates, Inc.